You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
Despite the remarkable enhancements in breast cancer classification and characterization, an exhaustive comprehension of the underlying carcinogenic processes and an accurate prediction of its clinical behavior are yet to be achieved. On the wave of recent scientific advances and clinical findings, new cutting-edge technologies are poised to deliver an array of diverse molecular data that are expected to dramatically alter breast cancer diagnosis and treatment.
Footnotes
-
Citation: J. S. Reis-Filho, B. Weigelt, D. Fumagalli, C. Sotiriou, Molecular profiling: Moving away from tumor philately. Sci. Transl. Med. 2, 47ps43 (2010).
- Copyright © 2010, American Association for the Advancement of Science
